메뉴 건너뛰기




Volumn 47, Issue 3, 2010, Pages 344-345

Cervical cancer screening in developing countries

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DEVELOPING COUNTRY; FEMALE; HUMAN; LETTER; PAPANICOLAOU TEST; UTERINE CERVIX CANCER;

EID: 77954445351     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.64704     Document Type: Letter
Times cited : (11)

References (6)
  • 1
    • 16244411636 scopus 로고    scopus 로고
    • Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment
    • Yabroff KR, Lawrence WF, King JC, Mangan P, Washington KS, Yi B, et al. Geographic disparities in cervical cancer mortality: What are the roles of risk factor prevalence, screening, and use of recommended treatment. J Rural Health 2005;21:149-157
    • (2005) J Rural Health , vol.21 , pp. 149-157
    • Yabroff, K.R.1    Lawrence, W.F.2    King, J.C.3    Mangan, P.4    Washington, K.S.5    Yi, B.6
  • 2
    • 66149149866 scopus 로고    scopus 로고
    • Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India
    • Kaku M, Mathew A, Rajan B. Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pac J Cancer Prev 2008;9:589-594
    • (2008) Asian Pac J Cancer Prev , vol.9 , pp. 589-594
    • Kaku, M.1    Mathew, A.2    Rajan, B.3
  • 4
    • 36249021545 scopus 로고    scopus 로고
    • Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
    • Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370:1764-1772
    • (2007) Lancet , vol.370 , pp. 1764-1772
    • Bulkmans, N.W.1    Berkhof, J.2    Rozendaal, L.3    Van Kemenade, F.J.4    Boeke, A.J.5    Bulk, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.